Aleafia Health Income Statement

Financials in millions CAD. Fiscal year is April - March.

Millions CAD. Fiscal year is Apr - Mar.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Revenue	42.85	34.5	36.08	36.28	16.35
Revenue Growth (YoY)	24.20%	-4.39%	-0.53%	121.85%	391.02%
Cost of Revenue	36.85	44.05	48.05	51.22	-4.43
Gross Profit	6	-9.56	-11.97	-14.94	20.78
Selling, General & Admin	18.22	27.3	33.57	24.04	25.34
Operating Expenses	23.76	38.69	53.22	36.68	44.77
Operating Income	-17.76	-48.24	-65.19	-51.62	-23.98
Interest Expense	-9.36	-8.63	-8.16	-11.64	-5.96
Other Non Operating Income (Expenses)	-	0.01	0.28	0.48	0.3
EBT Excluding Unusual Items	-27.11	-56.86	-73.07	-62.78	-29.64
Merger & Restructuring Charges	-0.4	-	-	-	-5.21
Impairment of Goodwill	-	-9.05	-11.31	-177.48	-
Gain (Loss) on Sale of Investments	-1.11	-12.4	-14.39	0.94	-1.8
Gain (Loss) on Sale of Assets	0.09	9.67	12.09	1.18	-
Asset Writedown	-5.58	-65.51	-81.89	-22.12	-
Other Unusual Items	-0.5	-4.02	-	2.2	-
Pretax Income	-34.61	-138.18	-168.57	-258.05	-36.65
Income Tax Expense	-	-2.28	-2.85	-2.54	2.96
Net Income	-34.61	-135.89	-165.72	-255.51	-39.61
Net Income to Common	-34.61	-135.89	-165.72	-255.51	-39.61
Shares Outstanding (Basic)	386	327	326	292	216
Shares Outstanding (Diluted)	386	327	326	292	216
Shares Change (YoY)	18.15%	0.31%	11.80%	35.23%	84.04%
EPS (Basic)	-0.09	-0.42	-0.51	-0.88	-0.18
EPS (Diluted)	-0.09	-0.42	-0.51	-0.88	-0.18
Free Cash Flow	-5.13	-29.44	-36.67	-25.41	-54.26
Free Cash Flow Per Share	-0.01	-0.09	-0.11	-0.09	-0.25
Gross Margin	14.00%	-27.70%	-33.18%	-41.19%	127.10%
Operating Margin	-41.44%	-139.85%	-180.66%	-142.30%	-146.68%
Profit Margin	-80.77%	-393.92%	-459.26%	-704.36%	-242.23%
Free Cash Flow Margin	-11.98%	-85.34%	-101.63%	-70.04%	-331.84%
EBITDA	-11.78	-38.59	-55.39	-42.15	-18.07
EBITDA Margin	-27.49%	-111.87%	-153.51%	-116.19%	-110.52%
D&A For EBITDA	5.98	9.65	9.8	9.47	5.91
EBIT	-17.76	-48.24	-65.19	-51.62	-23.98
EBIT Margin	-41.44%	-139.85%	-180.66%	-142.30%	-146.68%
Revenue as Reported	42.85	34.5	36.08	36.28	16.35

Source: S&P Global Market Intelligence. Standard template. Financial Sources.